Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference11 articles.
1. Anand S, Agarwala S, Jain V, et al. Management and outcomes of children with stage 4S (MS) neuroblastoma: a single-center experience from a resource-challenged nation. Indian J Pediatr. 2022. https://doi.org/10.1007/s12098-022-04341-7.
2. Bansal D, Marwaha RK, Trehan A, Rao KLN, Gupta V. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than one year: a 15-years experience. Indian Pediatr. 2008;45:135–9.
3. Kusumakumary P, Ajithkumar TV, Ratheesan K, Chellam VG, Nair MK. Pattern and outcome of neuroblastoma. A 10 year study. Indian Pediatr. 1998;35:223–9.
4. Twist CJ, Naranjo A, Schmidt ML, et al. Defining risk factors for chemotherapeutic intervention in infants with stage 4S neuroblastoma: a report from Children’s Oncology Group Study ANBL0531. J Clin Oncol. 2019;37:115–24.
5. Taggart DR, London WB, Schmidt ML, et al. Prognostic value of the stage 4s metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age. J Clin Oncol. 2011;29:4358–64.